INT32858

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.66
First Reported 1985
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 9
Total Number 9
Disease Relevance 2.86
Pain Relevance 1.60

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
muscle 2
skin 1
heart 1
ECT (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 5 99.76 Very High Very High Very High
narcan 4 99.62 Very High Very High Very High
antidepressant 65 99.00 Very High Very High Very High
opiate 2 98.62 Very High Very High Very High
anesthesia 27 98.44 Very High Very High Very High
depression 127 94.84 High High
magnetoencephalography 1 91.52 High High
Transcranial magnetic stimulation 22 89.04 High High
gABA 1 68.88 Quite High
Neurotransmitter 11 67.36 Quite High
Disease Link Frequency Relevance Heat
Cv General 3 Under Development 5 99.76 Very High Very High Very High
Neurological Disease 4 99.24 Very High Very High Very High
Cancer 19 97.40 Very High Very High Very High
Metastasis 16 97.08 Very High Very High Very High
Bites And Stings 3 95.80 Very High Very High Very High
Skin Cancer 5 94.96 High High
Depression 178 94.88 High High
Solid Tumor 1 94.04 High High
Carcinoma 1 93.48 High High
Sarcoma 1 93.00 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
This demand and supply gap is exploited by the unregulated private health sector, notorious for its use of 'unmodified' ECT (ECT conducted without the use of adequate anesthesia or muscle relaxants, which can cause fractures, tongue bites, and an enormous amount of mental and physical anguish [5]).
Localization (use) of ECT in muscle associated with anesthesia and bites and stings
1) Confidence 0.66 Published 2007 Journal BMC Psychiatry Section Body Doc Link PMC1929082 Disease Relevance 0.40 Pain Relevance 0.13
Recipients of ECT were further asked about their source of referral, the treatment method and if their consent had been taken.


Localization (Recipients) of ECT
2) Confidence 0.66 Published 2007 Journal BMC Psychiatry Section Body Doc Link PMC1929082 Disease Relevance 0.13 Pain Relevance 0.03
This demand and supply gap is exploited by the unregulated private health sector, notorious for its use of 'unmodified' ECT (ECT conducted without the use of adequate anesthesia or muscle relaxants, which can cause fractures, tongue bites, and an enormous amount of mental and physical anguish [5]).
Localization (use) of ECT in muscle associated with anesthesia and bites and stings
3) Confidence 0.66 Published 2007 Journal BMC Psychiatry Section Body Doc Link PMC1929082 Disease Relevance 0.40 Pain Relevance 0.13
A minority thought that ECT was used only in the poor and should not be given to the elderly or children.
Localization (used) of ECT
4) Confidence 0.64 Published 2009 Journal J ECT Section Body Doc Link 19057398 Disease Relevance 0 Pain Relevance 0
It is unclear whether ECT, which transiently, yet markedly, increases blood pressure and heart rate, can be safely performed in patients with AAA.
Localization (performed) of ECT in heart associated with cva
5) Confidence 0.64 Published 2009 Journal J ECT Section Abstract Doc Link 19730028 Disease Relevance 0.46 Pain Relevance 0.28
Of those 21 ECT patients who were rejected, one patient did not give her consent to the study, eight patients received bifrontal (BF) ECT as a part of a preliminary study comparing the effects of BF and RUL ECT, five patients participated in the ongoing magnetoencephalography ECT study, two patients refused to discontinue the antidepressant medication, three patient received outpatient ECT, one patient received bitemporal (BT) ECT for schizophrenia, and one patient BT ECT for catatonia.
Localization (rejected) of ECT associated with magnetoencephalography, antidepressant, catatonia and schizophrenia
6) Confidence 0.56 Published 2002 Journal BMC Psychiatry Section Body Doc Link PMC65527 Disease Relevance 0.48 Pain Relevance 0.24
Currently, ECT is applied mainly in the treatment of secondary cutaneous and subcutaneous tumors (metastases) of any histological origin, ie, not only skin cancers, but also solid tumors, carcinomas, sarcomas, and so on that give rise to cutaneous and subcutaneous metastases.
Localization (applied) of ECT in skin associated with sarcoma, cancer, carcinoma, solid tumor, skin cancer and metastasis
7) Confidence 0.28 Published 2008 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2504052 Disease Relevance 0.77 Pain Relevance 0
In the last few decades it has received considerable interest as a therapeutic tool in a variety of neurological disorders, stemming from its favorable spatial selectivity over ECT, noninvasive nature, and generally tolerable side effects (Figiel et al., 1998; Klein et al., 1999; Janicak et al., 2008).
Localization (selectivity) of ECT associated with neurological disease
8) Confidence 0.10 Published 2010 Journal Frontiers in Neuroengineering Section Body Doc Link PMC2901135 Disease Relevance 0.21 Pain Relevance 0.48
Opiate receptor blockade with low- or high-dose naloxone did not alter the release of PRL or cortisol after ECT.
Localization (release) of ECT associated with narcan and opiate
9) Confidence 0.05 Published 1985 Journal Biol. Psychiatry Section Abstract Doc Link 2986737 Disease Relevance 0 Pain Relevance 0.32

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox